Fate Therapeutics IncNASDAQ:FATE
- LAST PRICE3.7700
- TODAY'S CHANGE (%)-0.1200 (-3.0848%)
- Bid / Lots3.4000/ 5
- Ask / Lots4.0500/ 2
- Open / Previous Close4.0100 / 3.8900
- Day Range
- 52 Week Range
- Volume1,688,638
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FATE |
|---|---|---|
| 09:32 ET | 26610 | 4.155 |
| 09:34 ET | 11689 | 4.1 |
| 09:36 ET | 3518 | 4.09 |
| 09:38 ET | 1649 | 4.07 |
| 09:39 ET | 3200 | 4.07 |
| 09:41 ET | 5312 | 4.06 |
| 09:43 ET | 5500 | 4.085 |
| 09:45 ET | 7162 | 4.075 |
| 09:48 ET | 6685 | 4.085 |
| 09:50 ET | 4297 | 4.065 |
| 09:52 ET | 4444 | 4.03 |
| 09:54 ET | 698 | 4.055 |
| 09:56 ET | 5769 | 4.07 |
| 09:57 ET | 300 | 4.07 |
| 09:59 ET | 1500 | 4.06 |
| 10:01 ET | 29212 | 4.045 |
| 10:03 ET | 1808 | 4.02 |
| 10:06 ET | 1392 | 4.015 |
| 10:08 ET | 3058 | 4.01 |
| 10:10 ET | 1646 | 4.01 |
| 10:12 ET | 5306 | 4 |
| 10:14 ET | 24442 | 3.975 |
| 10:15 ET | 1635 | 3.985 |
| 10:17 ET | 1938 | 3.99 |
| 10:19 ET | 7415 | 3.9929 |
| 10:21 ET | 1923 | 3.99 |
| 10:24 ET | 9498 | 4.005 |
| 10:26 ET | 3190 | 3.985 |
| 10:28 ET | 1480 | 4 |
| 10:30 ET | 1493 | 3.99 |
| 10:32 ET | 2136 | 3.98 |
| 10:33 ET | 1465 | 4 |
| 10:35 ET | 1009 | 3.995 |
| 10:37 ET | 9100 | 4 |
| 10:39 ET | 4907 | 4 |
| 10:42 ET | 3346 | 3.97 |
| 10:44 ET | 3392 | 3.95 |
| 10:46 ET | 22150 | 3.975 |
| 10:48 ET | 1742 | 3.975 |
| 10:50 ET | 1199 | 3.965 |
| 10:51 ET | 2599 | 3.97 |
| 10:53 ET | 2619 | 3.97 |
| 10:55 ET | 3482 | 3.985 |
| 10:57 ET | 69475 | 3.98 |
| 11:00 ET | 1766 | 3.965 |
| 11:02 ET | 726 | 3.96 |
| 11:04 ET | 2200 | 3.945 |
| 11:06 ET | 11718 | 3.965 |
| 11:08 ET | 7607 | 3.975 |
| 11:09 ET | 7014 | 3.975 |
| 11:11 ET | 705 | 3.975 |
| 11:13 ET | 19903 | 3.985 |
| 11:15 ET | 16204 | 3.95 |
| 11:18 ET | 3965 | 3.95 |
| 11:20 ET | 4343 | 3.95 |
| 11:22 ET | 1000 | 3.945 |
| 11:24 ET | 23835 | 3.935 |
| 11:26 ET | 948 | 3.93 |
| 11:27 ET | 17695 | 3.92 |
| 11:29 ET | 1601 | 3.92 |
| 11:31 ET | 2871 | 3.92 |
| 11:33 ET | 12995 | 3.92 |
| 11:36 ET | 2669 | 3.91 |
| 11:38 ET | 938 | 3.91 |
| 11:40 ET | 1600 | 3.9125 |
| 11:42 ET | 733 | 3.91 |
| 11:44 ET | 10733 | 3.915 |
| 11:45 ET | 1231 | 3.9 |
| 11:47 ET | 1500 | 3.9089 |
| 11:49 ET | 626 | 3.905 |
| 11:51 ET | 625 | 3.9 |
| 11:54 ET | 400 | 3.9091 |
| 11:56 ET | 1123 | 3.905 |
| 11:58 ET | 7296 | 3.895 |
| 12:00 ET | 5930 | 3.909 |
| 12:02 ET | 534 | 3.905 |
| 12:03 ET | 1683 | 3.905 |
| 12:05 ET | 1370 | 3.9 |
| 12:07 ET | 300 | 3.9 |
| 12:09 ET | 2933 | 3.91 |
| 12:12 ET | 3093 | 3.89 |
| 12:14 ET | 7684 | 3.9 |
| 12:16 ET | 16915 | 3.865 |
| 12:20 ET | 512 | 3.8688 |
| 12:21 ET | 2986 | 3.855 |
| 12:23 ET | 2931 | 3.865 |
| 12:25 ET | 10282 | 3.875 |
| 12:27 ET | 200 | 3.87 |
| 12:30 ET | 919 | 3.875 |
| 12:32 ET | 8942 | 3.875 |
| 12:34 ET | 5916 | 3.87 |
| 12:36 ET | 5421 | 3.88 |
| 12:38 ET | 300 | 3.885 |
| 12:39 ET | 1001 | 3.875 |
| 12:41 ET | 5645 | 3.865 |
| 12:43 ET | 426 | 3.865 |
| 12:45 ET | 343 | 3.865 |
| 12:48 ET | 900 | 3.865 |
| 12:50 ET | 100 | 3.865 |
| 12:52 ET | 1084 | 3.86 |
| 12:54 ET | 300 | 3.865 |
| 12:56 ET | 963 | 3.86 |
| 12:57 ET | 5596 | 3.86 |
| 12:59 ET | 822 | 3.86 |
| 01:01 ET | 12377 | 3.86 |
| 01:03 ET | 619 | 3.86 |
| 01:06 ET | 585 | 3.855 |
| 01:08 ET | 17411 | 3.875 |
| 01:10 ET | 8801 | 3.88 |
| 01:12 ET | 1760 | 3.88 |
| 01:14 ET | 1129 | 3.88 |
| 01:15 ET | 8369 | 3.875 |
| 01:17 ET | 2289 | 3.88 |
| 01:19 ET | 7459 | 3.855 |
| 01:21 ET | 847 | 3.855 |
| 01:24 ET | 6148 | 3.85 |
| 01:26 ET | 3672 | 3.86 |
| 01:28 ET | 2244 | 3.865 |
| 01:30 ET | 500 | 3.865 |
| 01:32 ET | 6148 | 3.87 |
| 01:33 ET | 2528 | 3.86 |
| 01:35 ET | 540 | 3.865 |
| 01:37 ET | 5600 | 3.86 |
| 01:39 ET | 2557 | 3.87 |
| 01:42 ET | 487 | 3.88 |
| 01:44 ET | 300 | 3.87 |
| 01:46 ET | 584 | 3.875 |
| 01:48 ET | 6847 | 3.89 |
| 01:50 ET | 3270 | 3.895 |
| 01:51 ET | 1398 | 3.885 |
| 01:55 ET | 2060 | 3.875 |
| 01:57 ET | 1915 | 3.88 |
| 02:00 ET | 200 | 3.875 |
| 02:02 ET | 18069 | 3.87 |
| 02:04 ET | 5402 | 3.87 |
| 02:06 ET | 3699 | 3.87 |
| 02:08 ET | 2707 | 3.86 |
| 02:09 ET | 1822 | 3.86 |
| 02:11 ET | 6150 | 3.855 |
| 02:13 ET | 797 | 3.85 |
| 02:15 ET | 427 | 3.855 |
| 02:18 ET | 4618 | 3.86 |
| 02:20 ET | 2984 | 3.86 |
| 02:22 ET | 724 | 3.855 |
| 02:24 ET | 1501 | 3.845 |
| 02:26 ET | 1682 | 3.85 |
| 02:27 ET | 3881 | 3.845 |
| 02:29 ET | 3339 | 3.85 |
| 02:31 ET | 5878 | 3.85 |
| 02:33 ET | 5198 | 3.855 |
| 02:36 ET | 536 | 3.855 |
| 02:38 ET | 9086 | 3.87 |
| 02:40 ET | 8698 | 3.87 |
| 02:42 ET | 6701 | 3.85 |
| 02:44 ET | 4821 | 3.83 |
| 02:45 ET | 6096 | 3.81 |
| 02:47 ET | 4414 | 3.8 |
| 02:49 ET | 13219 | 3.78 |
| 02:51 ET | 4069 | 3.785 |
| 02:54 ET | 7720 | 3.77 |
| 02:56 ET | 4119 | 3.765 |
| 02:58 ET | 6059 | 3.785 |
| 03:00 ET | 8044 | 3.77 |
| 03:02 ET | 4544 | 3.79 |
| 03:03 ET | 4859 | 3.79 |
| 03:05 ET | 4418 | 3.775 |
| 03:07 ET | 7220 | 3.77 |
| 03:09 ET | 400 | 3.775 |
| 03:12 ET | 6730 | 3.785 |
| 03:14 ET | 4476 | 3.77 |
| 03:16 ET | 8769 | 3.78 |
| 03:18 ET | 3149 | 3.785 |
| 03:20 ET | 4564 | 3.78 |
| 03:21 ET | 2157 | 3.785 |
| 03:23 ET | 9507 | 3.785 |
| 03:25 ET | 6166 | 3.755 |
| 03:27 ET | 8671 | 3.7634 |
| 03:30 ET | 7144 | 3.745 |
| 03:32 ET | 4677 | 3.74 |
| 03:34 ET | 11147 | 3.745 |
| 03:36 ET | 6604 | 3.74 |
| 03:38 ET | 3394 | 3.74 |
| 03:39 ET | 7677 | 3.735 |
| 03:41 ET | 5500 | 3.735 |
| 03:43 ET | 11994 | 3.735 |
| 03:45 ET | 18885 | 3.745 |
| 03:48 ET | 9456 | 3.755 |
| 03:50 ET | 13780 | 3.755 |
| 03:52 ET | 14181 | 3.765 |
| 03:54 ET | 12074 | 3.775 |
| 03:56 ET | 24662 | 3.775 |
| 03:57 ET | 46095 | 3.775 |
| 03:59 ET | 302403 | 3.77 |
Jun 4, 2024
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4), from 4:01PM ET on Tuesday Jun 04, 2024 by Dow Jones
4:01PM ET on Tuesday Jun 04, 2024 by Dow Jones
May 29, 2024
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference, from 4:01PM ET on Wednesday May 29, 2024 by Dow Jones
4:01PM ET on Wednesday May 29, 2024 by Dow Jones
May 16, 2024
DJ Fate Therapeutics Is Maintained at Neutral by HC Wainwright & Co., from 7:49AM ET on Thursday May 16, 2024 by Dow Jones
7:49AM ET on Thursday May 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fate Therapeutics Inc | 439.4M | -2.0x | --- |
Editas Medicine Inc | 437.5M | -2.9x | --- |
Contineum Therapeutics Inc | 461.0M | 21.9x | --- |
ADC Therapeutics SA | 350.1M | -1.1x | --- |
Urogen Pharma Ltd | 461.4M | -3.8x | --- |
MacroGenics Inc | 286.9M | -13.3x | --- |
Company Information
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Contact Information
- Headquarters
- 12278 Scripps Summit DriveSAN DIEGO, CA, United States 92131
- Phone
- 858-875-1803
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- William Rastetter
- President, Chief Executive Officer, Chief Financial Officer, Principal Financial and Accounting Officer, Director
- John Wolchko
- Independent Vice Chairman of the Board
- John Mendlein
- Chief Financial Officer
- Edward Dulac
- General Counsel, Corporate Secretary
- Cindy Tahl
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $439.4M |
|---|---|
Revenue (TTM) | $6.5M |
Shares Outstanding | 113.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.92 |
EPS | $-1.92 |
Book Value | $3.74 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 67.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,287.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
